Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

Sir Andrew Witty announces decision to step down as CEO of GSK

March 17, 2016 Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down

Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …
News
gsk_sign_good

GSK’s asthma drug meets primary goal in safety study for children

March 17, 2016 Research and Development Advair Diskus, GSK, asthma, drug trial

GlaxoSmithKline (LSE: GSK) said on Thursday its asthma drug met the primary end point in a second study for children. …
News
nice

Amgen skin cancer drug Imlygic rejected by NICE

March 16, 2016 Research and Development Amgen, Imlygic, NICE, melanoma, skin cancer

NICE has rejected Amgen’s drug Imlygic (talimogene laherparepvec) in draft as a treatment for advanced melanoma that has spread and …
News
asthma_inhalers

Vectura agree £441m merger with Skyepharma

March 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura

Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …
News
shutterstock_159488225

Vaxon Biotech completes enrollment for mid-stage trial of lung cancer vaccine

March 16, 2016 Research and Development, Sales and Marketing NSCLC, immuno-oncology, vaxon biotech

Vaxon Biotech on Wednesday said it has completed the enrollments for mid-stage trials of its vaccine to treat non-small-cell lung …
News
gsk_l_rgb-web

GSK establish cell and gene therapy collaboration with Miltenyi Biotec

March 16, 2016 Medical Communications, Research and Development GSK, GlaxoSmithKline, cell and gene therapy, collaboration, miltenyi biotec

GlaxoSmithKline (NYSE:GSK) has announced a strategic collaboration with Miltenyi Biotec that will see GSK’s expertise in developing cell and gene …
News

Blueprint Medicines agrees $1 billion-plus deal with Roche for cancer therapy

March 16, 2016 Business Services, Research and Development, Sales and Marketing Blueprint Medicines, Deals, Immunokinases, Roche, drug development

Blueprint Medicines Corp (Nasdaq: BPMC) said it has signed an over $1 billion deal with oncology drug giant Roche (SIX: ROG) …
News
aedes_aegypti_mosquito

New research supports association between Zika virus and microcephaly

March 16, 2016 Medical Communications, Research and Development Lancet, Zika virus, french polynesia, microcephaly, outbreak

Using data from the 2013-14 outbreak of Zika virus in French Polynesia, new research in The Lancet has further supported …
News
bruce_roberts_vedanta

PureTech’s Vedanta Biosciences appoints former Genzyme VP chief scientific officer

March 16, 2016 Medical Communications, Research and Development Bruce Roberts, Genzyme, Vedanta Biosciences

Vedanta Biosciences, a company developing therapies designed to modulate the human microbiome, has appointed former Genzyme group vice president, Bruce …
Appointment
celatorpharmalogo

Celator’s shares jump on positive late-stage trials for leukaemia drug

March 16, 2016 Business Services, Research and Development, Sales and Marketing Celator Pharmaceuticals, EMA, US FDA, Vyxeos, drug trials, phase III

Shares in trial-stage Celator Pharmaceuticals (Nasdaq: CPXX) soared gaining over four times in value as the company announced late-stage trials …
News
abbottweb

FDA says benefits outweigh risks in Abbott’s heart stent, Absorb

March 16, 2016 Research and Development, Sales and Marketing Abbott, absorb, bioresorbable, coronary artery disease

An independent panel convened by the US Food and Drug Administration (FDA) has unanimously voted that the benefits of Absorb, …
News
sanofi_dice

Sanofi to use DiCE Molecules’ platform to boost drug discovery

March 16, 2016 Research and Development DiCE Molecules, Sanofi

Sanofi has announced a research partnership with newly-launched DiCE Molecules in which the French pharma giant will use DiCE’s small …
News
teva_copy

Teva says closing buy of Allergan’s generics biz may take longer

March 16, 2016 Business Services, Research and Development, Sales and Marketing Allergan, M&A, MA, Pfizer, Teva

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA) said its $40.5 billion acquisition of Allergan’s generics business will take longer than expected, …
News
eli_lilly

Lilly changes Alzheimer’s trial endpoint – shares fall

March 16, 2016 Research and Development Alzheimer's disease, Eli Lilly, solanezumab

Shares in Eli Lilly fell more than 4% yesterday when it announced it was changing the primary endpoint of a closely-watched …
News
shutterstock_244903099

InVivo Therapeutics to sell stake in company; shares drop

March 15, 2016 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing InVivo Therapeutics, Stake sale, stocks

InVivo Therapeutics (Nasdaq: NVIV) said it plans to sell an additional stake in the company to raise funds for its ongoing …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026